Indane compounds

Details Indane compounds Indane compounds

2007-08-30

2009-11-17

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S323000, C514S414000, C514S415000, C514S210180, C514S317000, C514S231200, C544S143000, C546S201000, C548S950000, C548S518000, C548S465000, C548S503000

Reexamination Certificate

active

07618967

ABSTRACT:
The invention provides novel indane compounds which are useful in the treatment of affective disorders, pain disorders, attention deficit hyperactivity disorder (ADHD), cognitive disorders, substance abuse, smoking cessation and stress urinary incontinence.

REFERENCES:
patent: 4873344 (1989-10-01), Bogeso et al.
patent: 5559134 (1996-09-01), Buchmann et al.
patent: 5773463 (1998-06-01), Harling et al.
patent: 6268535 (2001-07-01), Moussa et al.
patent: 2005/0085530 (2005-04-01), Bogeso et al.
patent: 0 271 225 (1988-06-01), None
patent: WO 92/10192 (1992-06-01), None
patent: WO 93/22293 (1993-11-01), None
patent: WO 94/04522 (1994-03-01), None
patent: WO 95/04027 (1995-02-01), None
patent: WO 95/04028 (1995-02-01), None
patent: WO 95/18617 (1995-07-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 96/06840 (1996-03-01), None
patent: WO 98/55447 (1998-12-01), None
patent: WO 99/35119 (1999-07-01), None
patent: WO 01/10842 (2001-02-01), None
patent: WO 2003/055873 (2003-07-01), None
patent: WO 2004/026237 (2004-04-01), None
patent: WO 2005/016901 (2005-02-01), None
patent: WO 2005/061455 (2005-07-01), None
patent: WO 2005/092854 (2005-10-01), None
patent: WO 2006/086984 (2006-08-01), None
patent: WO 2007/073503 (2007-06-01), None
Klaus P. Bogeso et al.: “3-phenyl-1-indanamines. Potential Antidepressant Activity and Potent Inhibition of Dopamine, Norepinephrine, and Serotonin Uptake”, J. Med. Chem., vol. 28, No. 12, 1985, p. 1817-1828.
Clar, E., et al., “New Benzenogenic Diene Syntheses”, Tetrahedron, 1974, 30:3293-3298.
Durani, N., et al., “Structure-Activity Relationship Of Antiestrogens: A Study Using Triarylbutenone, Benzofuran, and Triarylfuran Analogues as Models for Triarylethylenes and Triarylpropenones”, J. Med. Chem., 1989, 32(8):1700-1707.
Ecker, G., et al., “Structure-Activity Relationship Studies on Benzofuran Analogs of Propafenone-Type Modulators of Tumor Cell Multidrug Resistance”, J. Med. Chem., 1996, 39(24):4767-4774.
Johnston, K. M., and Shotter, R. G., “Friedel-Crafts Cyclisation—IV. Intramolecular vs Intermolecular Acylation with beta-Aryl Derivatives of Propionyl Chloride In Aromatic Substrates”, Tetrahedron, 1974, 30:4059-4064.
Khan, A., et al., “Venlafaxine in Depressed Outpatients”, Psychopharmacology Bulletin, 1991, 27(2):141-144.
Smonou, T. and Orfanopoulos, M., “Convenient Synthetic Sequence for the Preparation of Indanones”, Synthetic Communications, 1990, 20(9):1387-1397.
Sommer, M. B., et al., “Application of (2-Cyanoaryl)arylacetonitriles in Cyclization and Annulation Reactions. Preparation Of 3-Arylindans, 4-Aryl-3,4-dihydronaphthalenes, 4-Arylisoquinolines, 1-Aminonaphthalenes, and Heterocyclic Analogues”, J. Org. Chem., 1990, 55(16):4822-4827.
Wong, D.T., “Duloxetine (LY 248686): an inhibitor of serotonin and noradrenaline uptake and an antidepressant drug candidate”, Exp. Opin. Invest. Drugs, 1998, 7(10):1691-1699.
Zaidlewicz, M., et al., “Asymmetric synthesis of (S)-bufaralol and a propafenone analogue”, Tetrahedron: Asymmetry, 2003, 14:1659-1664.

Affiliated with

Also associated with

Rating

Indane compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indane compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indane compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4133065